Iodo benzene diacetate → Tert-butyl (1-(2-(7-iodo-[1,2,4]triazolo[4,3-a]pyridin-3-yl)quinolin-8-yl)piperidin-4-yl)methylcarbamate

HRID 339675

Reaktionsgleichung

Reaktionsgleichung von HRID 339675
[C:1]([O:5][C:6](=[O:35])[NH:7][CH2:8][CH:9]1[CH2:14][CH2:13][N:12]([C:15]2[CH:16]=[CH:17][CH:18]=[C:19]3[C:24]=2[N:23]=[C:22](/[CH:25]=[N:26]/[NH:27][C:28]2[CH:33]=[C:32]([I:34])[CH:31]=[CH:30][N:29]=2)[CH:21]=[CH:20]3)[CH2:11][CH2:10]1)([CH3:4])([CH3:3])[CH3:2].C(O)(=O)C.C(O)(=O)C.IC1C=CC=CC=1>>[C:1]([O:5][C:6](=[O:35])[NH:7][CH2:8][CH:9]1[CH2:14][CH2:13][N:12]([C:15]2[CH:16]=[CH:17][CH:18]=[C:19]3[C:24]=2[N:23]=[C:22]([C:25]2[N:29]4[CH:30]=[CH:31][C:32]([I:34])=[CH:33][C:28]4=[N:27][N:26]=2)[CH:21]=[CH:20]3)[CH2:11][CH2:10]1)([CH3:4])([CH3:2])[CH3:3]

Komponenten

3

Versuchsvorschrift

To (E)-tert-butyl(1-(2-((2-(4-iodopyridin-2-yl)hydrazono)methyl)quinolin-8-yl)piperidin-4-yl)methylcarbamate (178 mg, 0.304 mmol) was added iodobenzene diacetate (IBD) (127 mg, 0.395 mmol). The reaction was stirred for 2 hours. Additional IBD (0.5 eq) was added and the reaction was stirred for another 2 hours and then quenched with saturated Na2S2O3 (5 mL). The organic layer was extracted with DCM, dried (Na2SO4) and concentrated. The crude material was purified by silica gel chromatography (EtOAc/Hexane/MeOH 2:1:0.1) to provide the final product.

Aufarbeitung

  1. stirringthe reaction was stirred for another 2 hours
  2. customquenched with saturated Na2S2O3 (5 mL)
  3. extractionThe organic layer was extracted with DCM
  4. dry with materialdried (Na2SO4)
  5. concentrationconcentrated
  6. customThe crude material was purified by silica gel chromatography (EtOAc/Hexane/MeOH 2:1:0.1)

Quellen und Nachweise

ORD-Eintrag
ord-3d3ae3d7a8964504ac31314a2227c392
Quelldatensatz
uspto-grants-2014_11
Patentnummer
US08895550B2

Verknüpfte Notizen

Wird geladen…